# Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain

> **NCT00237341** · PHASE4 · COMPLETED · sponsor: **PriCara, Unit of Ortho-McNeil, Inc.** · enrollment: 358 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT00237341
- **Lead sponsor:** PriCara, Unit of Ortho-McNeil, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237341, "Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00237341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*